Carvedilol Tablet, Film Coated
Product Images NDC 71335-2101

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 71335-2101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 01)

Chemical structure of Carvedilol, showing its molecular components and bonds, as depicted in a structural formula diagram.*

FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 02)

A line graph depicting percentage mortality over 21 months comparing Carvedilol and placebo groups. The vertical axis shows % mortality from 0 to 30, and the horizontal axis represents time in months from 0 to 21. Two lines illustrate mortality trends for placebo and Carvedilol, with a noted P-value of 0.0014 indicating statistical comparison between groups.*

FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 03)

A forest plot depicting hazard ratios with confidence intervals for various subgroups including sex, age, race, diabetic status, ischemic status, heart rate, systolic blood pressure, and spironolactone use, as well as an overall category of all patients. The horizontal axis ranges approximately from 0.0 to 2.0, illustrating relative risk comparisons across these groups.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 04)

A line graph comparing the percentage of mortality over 24 months between placebo and carvedilol treatment groups. The vertical axis represents percentage mortality from 0 to 30%, and the horizontal axis shows time in months from 0 to 24. The graph indicates a statistically significant difference (P = 0.03) between the two groups, with the carvedilol group showing lower mortality rates over time.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 05)

A forest plot chart showing hazard ratios with confidence intervals for various patient subgroups. The chart compares groups by age, sex, prior conditions, Killip class, thrombolytic therapy, and clinical factors such as diabetes and blood pressure, depicting hazard ratios around 1.0 across these categories.*

FDA Label Image

Label (Lbl713352101)

Carvedilol 6.25 mg film-coated tablet label packaged by Bryant Ranch Prepack in Burbank, CA. The label references comparison to Coreg 6.25 mg tablets. It includes storage instructions to keep tightly closed and store at 20°-25°C (68°-77°F). The package count is 30 tablets with an NDC of 71335-2101.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.